Combined PET imaging of the inflammatory tumor microenvironment identifies margins of unique radiotracer uptake.

Zinnhardt B, Pigeon H, Thézé B, Viel T, Wachsmuth L, Fricke IB, Schelhaas S, Honold L, Schwegmann K, Wagner S, Faust A, Faber C, Kuhlmann MT, Hermann S, Schäfers M, Winkeler A, Jacobs AH. (2017)
In: Cancer Research, 77(8)
Type of Publication: Research article (journal)

Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid…

Ehlert A, Schmidt C, Wölfer J, Manthei G, Jacobs A, Brüning R, Heindel W, Ringelstein E, Stummer W, Pluta R, Hesselmann V. (2016)
In: Journal of Neurosurgery, 124(1)
Type of Publication: Research article (journal)

The relationship between endogenous thymidine concentrations and [18F]FLT uptake in a range of preclinical tumour models.

Heinzmann K, Honess D, Lewis D, Smith D, Cawthorne C, Keen H, Heskamp S, Schelhaas S, Witney T, Soloviev D, Williams K, Jacobs A, Aboagye E, Griffiths J, Brindle K. (2016)
In: EJNMMI Research, 6(1)
Type of Publication: Research article (journal)

Gemcitabine mechanism of action confounds early assessment of treatment response by 3′-Deoxy-3′-[18F]fluorothymidine in preclinical models of lung cancer.

Schelhaas S, Held A, Wachsmuth L, Hermann S, Honess D, Heinzmann K, Smith D, Griffiths J, Faber C, Jacobs A. (2016)
In: Cancer Research, 76(24)
Type of Publication: Research article (journal)

Mechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkers.

O’Halloran P, Viel T, Murray D, Wachsmuth L, Schwegmann K, Wagner S, Kopka K, Jarzabek M, Dicker P, Hermann S, Faber C, Klasen T, Schäfers M, O’Brien D, Prehn J, Jacobs A, Byrne A. (2016)
In: European Journal of Nuclear Medicine and Molecular Imaging, 43(9)
Type of Publication: Research article (journal)

Publications

Contact

Top-Links

A specific dietary intervention to restore brain structure and function after ischemic stroke. Wiesmann M, Zinnhardt B, Reinhardt D, Eligehausen S, Wachsmuth L, Hermann S, Dederen PJ, Hellwich M, Kuhlmann MT, Broersen LM, Heerschap A, Jacobs AH, Kiliaan AJ. (2017) In: Theranostics, 7(2) Type of Publication: Research article (journal)
Combined PET imaging of the inflammatory tumor microenvironment identifies margins of unique radiotracer uptake. Zinnhardt B, Pigeon H, Thézé B, Viel T, Wachsmuth L, Fricke IB, Schelhaas S, Honold L, Schwegmann K, Wagner S, Faust A, Faber C, Kuhlmann MT, Hermann S, Schäfers M, Winkeler A, Jacobs AH. (2017) In: Cancer Research, 77(8) Type of Publication: Research article (journal)
In vivo bioluminescence imaging of neurogenesis - the role of the blood brain barrier in an experimental model of Parkinson's disease. Fricke IB, Schelhaas S, Zinnhardt B, Viel T, Hermann S, Couillard-Després S, Jacobs AH. (2017) In: Eur J Neurosci., ejn.13540 Type of Publication: Research article (journal)
Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid… Ehlert A, Schmidt C, Wölfer J, Manthei G, Jacobs A, Brüning R, Heindel W, Ringelstein E, Stummer W, Pluta R, Hesselmann V. (2016) In: Journal of Neurosurgery, 124(1) Type of Publication: Research article (journal)
Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G. Kailayangiri S, Altvater B, Spurny C, Jamitzky S, Schelhaas S, Jacobs AH, Wiek C, Roellecke K, Hanenberg H, Hartmann W, Wiendl H, Pankratz S, Meltzer J, Farwick N, Greune L, Fluegge M, Rossig C. (2016) In: OncoImmunology, 6(1) Type of Publication: Research article (journal)
The relationship between endogenous thymidine concentrations and [18F]FLT uptake in a range of preclinical tumour models. Heinzmann K, Honess D, Lewis D, Smith D, Cawthorne C, Keen H, Heskamp S, Schelhaas S, Witney T, Soloviev D, Williams K, Jacobs A, Aboagye E, Griffiths J, Brindle K. (2016) In: EJNMMI Research, 6(1) Type of Publication: Research article (journal)
Preclinical evidence that 3′-deoxy-3′-[18F]fluorothymidine PET can visualize recovery of hematopoiesis after gemcitabine chemotherapy. Schelhaas S, Held A, Bäumer N, Viel T, Hermann S, Müller-Tidow C, Jacobs A. (2016) In: Cancer Research, 76(24) Type of Publication: Research article (journal)
Gemcitabine mechanism of action confounds early assessment of treatment response by 3′-Deoxy-3′-[18F]fluorothymidine in preclinical models of lung cancer. Schelhaas S, Held A, Wachsmuth L, Hermann S, Honess D, Heinzmann K, Smith D, Griffiths J, Faber C, Jacobs A. (2016) In: Cancer Research, 76(24) Type of Publication: Research article (journal)
6-hydroxydopamine-induced Parkinson's disease-like degeneration generates acute microgliosis and astrogliosis in the nigrostriatal system but no bioluminescence imaging-detectable… Fricke I, Viel T, Worlitzer M, Collmann F, Vrachimis A, Faust A, Wachsmuth L, Faber C, Dollé F, Kuhlmann M, Schäfers K, Hermann S, Schwamborn J, Jacobs A. (2016) In: European Journal of Neuroscience, 43(10) Type of Publication: Research article (journal)
Mechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkers. O’Halloran P, Viel T, Murray D, Wachsmuth L, Schwegmann K, Wagner S, Kopka K, Jarzabek M, Dicker P, Hermann S, Faber C, Klasen T, Schäfers M, O’Brien D, Prehn J, Jacobs A, Byrne A. (2016) In: European Journal of Nuclear Medicine and Molecular Imaging, 43(9) Type of Publication: Research article (journal)